Abstract. Histamine, prostaglandin E 2 , and catecholamines have been demonstrated to regulate the innate and acquired immune responses. In this review, we describe one of the mechanisms common to the action of these agonists; the regulation of the expression of costimulatory adhesion molecules such as ICAM-1 and B7 antigens on monocytes / macrophages. The specific receptor subtypes involved in the action of each agonist were H 2 for histamine, EP 2 / EP 4 for prostaglandin E 2 , and b 2 for catecholamines, all of which are coupled with adenylate cyclase via Gs protein. The regulation of the expression of adhesion molecules by these agonists in turn leads to the modulation of subsequent cytokine production mediated by cell-cell interaction under different stimuli. Histamine is synthesized in monocytes and T cells by the induction of histidine decarboxylase. The inducible histamine has different dynamics from that in storage granules of mast cells and basophils. Also, noradrenaline appears to be synthesized in lymphocytes. Thus, immune cells can produce histamine, prostaglandins, and noradrenaline by themselves and modulate the cell-cell interaction between monocytes and other cells. Some of the inhibitors of HMG-CoA reductase were shown to bind to the ICAM-1-binding domain of LFA-1, reducing the interaction mediated by ICAM-1 / LFA-1. The regulation of interaction mediated by adhesion molecules may provide a new target for controlling inflammatory and immune responses.
Introduction
The acquired immune response requires the engagement of T cells with antigen presenting cells (APC), mediated by the interaction of T cell receptor (TCR) with antigenic peptides presented by major histocompatibility complex (MHC) molecules on APC (1, 2) . These recognition and signaling events are now known to be controlled by a dynamic structure known as the immunological synapse, which is assembled upon the T cell-APC interface (1, 2) . In addition to TCR signaling, costimulatory signals are required for T cell activation from accessory receptors; the interaction of LFA-1 (CD11a/ CD18) with its ligand, ICAM-1 / CD54, and the binding of CD28 with CD80 (B7.1)/ CD86(B7.2) play important roles in cell signaling and cell-cell adhesion (1, 2) (Fig. 1) . Moreover, the novel B7 family on APC and their counter molecules on T cells can produce diverse patterns of T cell responses (1, 2) . Among them, the interaction of LFA-1 with ICAM-1 is important in the activation of T cells by lowering the concentration of antigen required for stimulation of T cells and promoting sustained signaling from TCR in a CD28-independent manner in acquired immune response (3) .
Recent studies identified the pattern recognition receptors, Toll-like receptors (TLR), which are involved in the innate immune response (4, 5) . The costimulatory adhesion molecules play crucial roles in the innate immune responses as well as in the acquired immune response (6) . Also, the activation of TLR on APC promotes the maturation of APC, influencing the acquired immune response. It has been well known that autacoids such as histamine and prostaglandin E 2 (PGE 2 ) and the sympathetic neurotransmitter noradrenaline exert profound effects on immune responses (7 -10) . In this review, we describe the effects of these substances on the expression of costimulatory adhesion molecules on monocytes and the subsequent modulation of cytokine production. We will also discuss the receptor subtypes involved in the regulation of costimulatory adhesion molecules and the endogenous autacoids-synthesizing ability in immune cells. Recently, it has been shown that some of the inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase have a unique pharmacological property, namely, interference of ICAM-1 / LFA-1 interaction by binding to LFA-1 (11) . Finally, we speculate on a novel strategy for controlling strong inflammatory and immune responses.
Increase in the expression of costimulatory adhesion molecules induced by IL-18 and LPS
IL-18 was originally identified as an interferon-ginducing factor and purified from the conditioned medium of Kupffer cells stimulated with LPS and Propionibacterium acnes (12) . IL-18 is functionally similar to IL-12 in that it mediates the Th1 response and induces NK activity (12) . IL-18 with IL-12 synergistically produced IFN-g in T lymphocytes and monocytic cells, in which IL-12 and IL-18 have been shown to upregulate the opposite receptor mutually.
In addition to the production of IL-18 in monocytes / macrophages, IL-18 is constitutively expressed in a number of epithelial cells including intestinal, airway, and skin epithelium, and the release of IL-18 can be induced by different stimuli (13 -15) . These modes of presence suggest the significant role of IL-18 in the early host defense mechanism. In a previous study, Yoshida et al. (16) demonstrated that IL-18 induced the production of IL-12, TNF-a , and IFN-g in the culture of human peripheral blood mononuclear cells (PBMC) without any commitment of antigen presentation. IL-18 appeared to have an effect on monocytes, which in turn induce the expression of ICAM-1 on the surface of monocytes as detected by FACS analysis (16 -18) . The production of TNF-a , IL-12 and IFN-g induced by IL-18 was inhibited by anti-ICAM-1 and anti-LFA-1 antibodies (16) . In parallel with the inhibition of cytokines induced by IL-18， antibodies against ICAM-1 and LFA-1 significantly inhibited the aggregatory response of PBMC (16) . Therefore, it was speculated that the IL-18-triggered interaction between monocytes and T/ NK through ICAM-1 and LFA-1 induced the production of TNF-a , IL-12, and IFN-g in PBMC without MHC and TCR commitment (16, 17) .
Recent studies identified the TLR family involved in the recognition of a broad range of molecular patterns of pathogens in the innate immune response (4, 5) . Among them, Toll-like receptor-4 (TLR-4)-MD2 was demonstrated to be a receptor for LPS and CD14 complex and transduces intracellular signals through the MyD88, IRAK, TRAF6, and NFk -B pathway, resulting in the production of cytokines including TNF-a (4, 5). Morichika et al. (6) observed that LPS increased the expression of ICAM-1, CD80, and CD86 on monocytes in human PBMC. Moreover, TNF-a production induced by LPS was partially inhibited by anti-ICAM-1, anti-CD80, or anti-CD86 antibody and the combination of these antibodies almost completely inhibited the TNF-a production (6). This finding indicated that LPS-induced TNF-a production in PBMC was dependent on cell-cell interaction through these adhesion molecules as observed in the case of IL-18 (6).
3. Regulation of IL-18-induced cytokine production by histamine, PGE 2 , and b 2 adrenergic agonist Histamine inhibited IL-18-induced production of TNF-a , IL-12, and IFN-g in human PBMC (17) . This histamine effect was antagonized by histamine H 2 -receptor antagonists, famotidine and ranitidine, but not by H 1 , H 3 , and H 4 antagonists. Moreover, H 2 -selective agonists, dimaprit and 4-methylhistamine, mimicked the effects of histamine on the cytokine production. The inhibition of cytokine production by histamine was accompanied with the inhibition of ICAM-1 on monocytes induced by IL-18, and the receptor subtypes involved in the regulation of ICAM-1 expression by hista- mine were demonstrated to have the same profile as those for the regulation of cytokine response (17) . The findings that IL-18-induced production of TNF-a , IL-12, and IFN-g in human PBMC was dependent on the interaction between ICAM and LFA-1 and that histamine efficiently inhibited the upregulation of ICAM-1 induced by IL-18 strongly indicate that histamine regulation of cytokine response to IL-18 was secondary to the effects on the expression of ICAM-1 on monocytes (17) .
As in the case of the IL-18-induced response, histamine concentration-dependently inhibited the expression of ICAM-1 and CD80 on monocytes induced by LPS, leading to the reduction of TNF-a production (6). The effect of histamine was again solely mediated by H 2 -receptors. These findings indicated that histamine may inhibit the innate immune response to the stimulation of TLR-4 on monocytes. Although histamine has been suspected to be one of the mediators of sepsis or septic shock, it appears to have protective effects on septic conditions via the inhibition of TNF-a production (6) .
The inhibitory effects of histamine on ICAM-1 expression and cytokine production were also observed in the human mixed lymphocyte reaction (MLR) in the presence of IL-18 (19) . MLR is an important in vitro model for studying alloresponsiveness. In human transplantation, the elevation of plasma IL-18 is associated with acute rejection and acute graft-versus-host disease. Thus, MLR in the presence of IL-18 provides such an in vitro condition. The presence of IL-18 significantly enhanced the expression of ICAM-1 on monocytes as well as the production of IFN-g and IL-12 (19) . Interestingly, histamine had inhibitory effects solely on the enhancing effects of IL-18 without any influence on basal MLR (19) . The histamine receptor subtypes involved were shown to be H 2 -receptors (19) .
In addition to histamine, PGE 2 (9) and catecholamines (10, 20) have been repeatedly reported to regulate the innate and acquired immune responses. Therefore, it was examined whether PGE 2 and catecholamines regulate the expression of ICAM-1 and B7 on monocytes induced by IL-18 (21, 22) . PGE 2 inhibited the IL-18-induced expression of ICAM-1 and CD86 on monocytes (21) . PGE 2 potentially stimulates four kinds of receptor subtypes, EP 1 , EP 2 , EP 3 , and EP 4 (23). Therefore, selective agonists for each receptor were used to determine the prostanoid receptors involved in the action of PGE 2 . The EP 2 -selective agonist ONO-AE1-259-01 and EP 4 selective agonist ONO-AE1-329 concentrationdependently inhibited the expression of ICAM-1 and CD86, whereas EP 1 -and EP 3 -selective agonists had no effects on the expression of adhesion molecules (21) .
The efficacy of EP 2 and EP 4 agonists on ICAM-1 was 60 and 40% of that obtained by PGE 2 , respectively. The EP 2 and EP 4 mixed agonist 11-deoxy-PGE 1 had similar potency and efficacy to PGE 2 . Thus, the effects of PGE 2 on IL-18-induced ICAM-1 and CD86 expression were concluded to be ascribed to the stimulation of both EP 2 and EP 4 (21) . Concerning the effects on human MLR, PGE 2 had a different profile from that of histamine. PGE 2 reduced the expression of ICAM-1, CD80, and CD86 on monocytes both in the absence and presence of IL-18 through the stimulation of EP 2 and EP 4 (24) .
The adrenergic neurotransmitter noradrenaline is released locally from sympathetic nerve terminals in lymphoid tissues (20) . The modulation of immune function by catecholamines is pleiotypic and affects a variety of cells of the immune system (10). Takahashi et al. (22) demonstrated the b 2 -regulation of ICAM-1 expression on monocytes induced by IL-18 in PBMC. The modulation of the expression of ICAM-1, CD80, and CD86 by histamine, PGE 2 , and salbutamol is compared in Fig. 2 . Also, the subsequent changes in cytokine production are summarized in Table 1 . Although H 2 -receptor, EP 2 / EP 4 and b 2 -receptor are all coupled with adenylate cyclase via Gs protein in many types of cells, the effect of salbutamol on CD86 expression was different from those of histamine, PGE 2 , dbcAMP, and forskolin. Thus, b 2 -receptors on monocytes may have an additional signal coupling to adenylate cyclase.
Endogenous production of histamine and catecholamines in the immune system
Histamine is a well-known storage amine of mast cells and basophils. The immunological release of histamine and the signal transduction mechanisms in these cells have been well documented. In addition to the immunological stimulus, TLR-2-mediated degranulation of mast cells was reported recently (25) . The other inflammatory and immunocompetent cells including macrophages, T cells, and neutrophils were reported to be capable of producing histamine (26 -28) . The mode of action and kinetics of histamine in these cells have been suggested to be different from those in mast cells and basophils (26, 27, 29) . Generally, this type of histamine was revealed to be inducible by LPS, T cell mitogen, and some cytokines (26, 27) . Table 2 summarizes a comparison of the nature of storage type and inducible histamine.
The sympathetic innervation of lymphoid organs has been well demonstrated (20) . The sympathetic nerve terminals form synapse-like junctions with immune cells (20) . Furthermore, the presence of catecholamines in immune cells free from sympathetic nerves was also detected by plural groups (30, 31) . They detected catecholamines and tyrosine hydroxylase activity in lymphocytes, especially after stimulation with phytohemagglutinin. The exact functional roles and the regulation of synthesis of endogenously produced catecholamines in immune cells remains to be determined; however, it is quite likely that endogenous catecholamines may influence monocytes/ macrophages in a paracrine fashion. Very interestingly, acetylcholine and choline acetyltransferase were also demonstrated in lymphocytes (32) . There is considerable evidence indicating the expression of cyclooxygenase-2 in macrophages, dendritic cells, and lymphocytes under certain conditions (33).
Statins as novel anti-inflammatory drugs
HMG-CoA reductase inhibitors (statins) lower the plasma cholesterol levels and have been used for the treatment of hypercholesterolemia and atherosclerosis. Recently, some of the HMG-CoA inhibitors were shown to bind to LFA-1 in the ICAM-1 binding domain, inhibiting the interaction of ICAM-1 and LFA-1 (34) . This effect of statins was expected to inhibit the adhesion of leukocytes to the vascular endothelial cells, reducing the infiltration of leukocytes from the blood to the inflammatory sites in the tissues. In fact, the infiltration of leukocytes into the peritoneal cavity by i.p. injection of thioglycolate in mice was dramatically reduced by pretreatment with LFA703, the most potent anti-LFA among statins, and anti-LFA-1 antibody (34). Also, there has been increasing evidence demonstrating antiinflammatory effects of statins on different inflammation models using experimental animals (35) . As mentioned above, the interaction of ICAM-1 and LFA-1 involves innate and acquired immune responses. Also, the epithelial cells express ICAM-1 upon activation on their surface, which is likely involved in the host defense mechanism by triggering interaction between epithelial cells and leukocytes. Thus, the regulation of the interaction of LFA-1 and ICAM-1 provides a novel target for controlling inflammatory as well as immune responses. In the present review, we described the regulation of cell-to-cell interaction by H 2 , EP 2 / EP 4 and b-receptors. These receptors have common signal coupling, however, the effects on CD86 expression and MLR were different. Thus, histamine, PGE 2 and catecholamines may play similar but distinct roles in regulating inflammatory and immune responses. The receptor-selective agonists together with statins may be useful for the treatment of transplant rejection, ischemia / reperfusion injury and inflammatory diseases.
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